These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 15849374

  • 1. Drug-induced myopathies. An overview of the possible mechanisms.
    Owczarek J, Jasińska M, Orszulak-Michalak D.
    Pharmacol Rep; 2005; 57(1):23-34. PubMed ID: 15849374
    [Abstract] [Full Text] [Related]

  • 2. Agents and mechanisms of toxic myopathy.
    Kuncl RW.
    Curr Opin Neurol; 2009 Oct; 22(5):506-15. PubMed ID: 19680127
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Statin-induced myopathy: the two faces of Janus.
    Arora R, Liebo M, Maldonado F.
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):105-12. PubMed ID: 16891287
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Managing the underestimated risk of statin-associated myopathy.
    Rallidis LS, Fountoulaki K, Anastasiou-Nana M.
    Int J Cardiol; 2012 Sep 06; 159(3):169-76. PubMed ID: 21813193
    [Abstract] [Full Text] [Related]

  • 7. Drug-induced myopathies.
    Bannwarth B.
    Expert Opin Drug Saf; 2002 May 06; 1(1):65-70. PubMed ID: 12904161
    [Abstract] [Full Text] [Related]

  • 8. Statin myopathy: an update.
    Christopher-Stine L.
    Curr Opin Rheumatol; 2006 Nov 06; 18(6):647-53. PubMed ID: 17053514
    [Abstract] [Full Text] [Related]

  • 9. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M, Corsini A, Roden M.
    Eur J Clin Invest; 2015 Jul 06; 45(7):745-54. PubMed ID: 25991405
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Toxic and drug-induced myopathies.
    Dalakas MC.
    J Neurol Neurosurg Psychiatry; 2009 Aug 06; 80(8):832-8. PubMed ID: 19608783
    [Abstract] [Full Text] [Related]

  • 15. Coenzyme Q10 and statin-related myopathy.
    Drug Ther Bull; 2015 May 06; 53(5):54-6. PubMed ID: 25977402
    [Abstract] [Full Text] [Related]

  • 16. Statin-induced myopathies.
    Tomaszewski M, Stępień KM, Tomaszewska J, Czuczwar SJ.
    Pharmacol Rep; 2011 May 06; 63(4):859-66. PubMed ID: 22001973
    [Abstract] [Full Text] [Related]

  • 17. Oxidative stress as a possible mechanism of statin-induced myopathy.
    Ahmadi Y, Ghorbanihaghjo A, Naghi-Zadeh M, Yagin NL.
    Inflammopharmacology; 2018 Jun 06; 26(3):667-674. PubMed ID: 29574631
    [Abstract] [Full Text] [Related]

  • 18. [Myopathies under therapy with lipid-lowering agents].
    Köller H, Neuhaus O, Schroeter M, Hartung HP.
    Nervenarzt; 2005 Feb 06; 76(2):212-7. PubMed ID: 15609055
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Statin myopathy: a review of recent progress.
    Mammen AL, Amato AA.
    Curr Opin Rheumatol; 2010 Nov 06; 22(6):644-50. PubMed ID: 20827205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.